ExLibris header image
SFX Logo
Title: Bioanalytical Approaches to Quantify “Total” and “Free” Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development
Source:

Aaps Journal [1550-7416] Lee, Jean yr:2011


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Lobo, Evelyn D D. "Antibody pharmacokinetics and pharmacodynamics." Journal of pharmaceutical sciences 93.11 (2004): 2645-2668. Link to Full Text for this item Link to SFX for this item
2. Danne, T. "New insulins and insulin therapy." International journal of clinical practice 1.SUPPL. 175 (2011): 26-34. Link to Full Text for this item Link to SFX for this item
3. Chen, G. "Characterization of protein therapeutics by mass spectrometry: recent developments and future directions." Drug discovery today 16.1-2 (2011): 58-64. Link to SFX for this item
4. Peck, G. "Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science." Annual Review of Pharmacology and Toxicology 51.1 (2010): 45-73. Link to Full Text for this item Link to SFX for this item
5. Davis, R.A. A. "A novel method for quantitative measurement of a biomarker in the presence of a therapeutic monoclonal antibody directed against the biomarker." Journal of Pharmaceutical and Biomedical Analysis 48.3 (2008): 897-901. Link to SFX for this item
6. Parrott, N. "Applications of physiologically based absorption models in drug discovery and development." Molecular pharmaceutics 5.5 (2008): 760-775. Link to Full Text for this item Link to SFX for this item
7. Ng, Chee M M. "Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers." Pharmaceutical Research 23.1 (2005): 95-103. Link to Full Text for this item Link to SFX for this item
8. Wang, W. "Monoclonal Antibody Pharmacokinetics and Pharmacodynamics." Clinical pharmacology and therapeutics 84.5 (2008): 548-558. Link to SFX for this item
9. Olczyk, P. "Interactions of short-acting, intermediate-acting and pre-mixed human insulins with free radicals—Comparative EPR examination." International journal of pharmaceutics 490.1-2 (2015): 9-15. Link to SFX for this item
10. Siebenhofer, A. "Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus." Cochrane Database of Systematic Reviews 2016.2 (2006): 3287-. Link to Full Text for this item Link to SFX for this item
11. Esposito, K. "Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes." Expert opinion on biological therapy 12.2 (2012): 209-221. Link to SFX for this item
12. Doyle, M. "Structural Mass Spectrometry in Protein Therapeutics Discovery." Analytical chemistry 82.17 (2010): 7083-7089. Link to Full Text for this item Link to SFX for this item
13. Tissot, B. "Glycoproteomics: Past, present and future." FEBS letters 583.11 (2009): 1728-1735. Link to Full Text for this item Link to SFX for this item
14. van Duijn, E. "Current Limitations in Native Mass Spectrometry Based Structural Biology." Journal of The American Society for Mass Spectrometry 21.6 (2010): 971-978. Link to SFX for this item
15. Lin, C.-C. C. "Microfluidic Immunoassays." JALA 15.3 (2010): 253-274. Link to SFX for this item
16. Zhang, Q.. "Evaluation of α-fetoprotein (AFP) in human serum by chemiluminescence enzyme immunoassay with magnetic particles and coated tubes as solid phases." Analytica Chimica Acta (2008). Link to SFX for this item
17. Stubenrauch, K. "Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates." Journal of Pharmaceutical and Biomedical Analysis 49.4 (2009): 1003-1008. Link to SFX for this item
18. Chen, Guodong D. "Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery." Journal of mass spectrometry 42.3 (2007): 279-287. Link to Full Text for this item Link to SFX for this item
19. Sanek, Ken. "Insulin Therapy." Clinical diabetes 20.4 (2002): 212-. Link to SFX for this item
20. Shoemaker, R. "The NCI60 human tumour cell line anticancer drug screen." Nature reviews. Cancer 6.10 (2006): 813-823. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced